Lv1
10 积分 2026-01-25 加入
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
5个月前
已完结
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps: The CROWNS-2 Randomized Clinical Trial
5个月前
已完结
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis
5个月前
已完结
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
5个月前
已完结
Stapokibart Rapidly and Consistently Improves the Clinical Signs Across All Body Regions in Adults With Moderate-to-Severe Atopic Dermatitis
5个月前
已完结
皖公网安备34019202002308
